Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cell-to-cell
100%
Cell Proliferation
100%
Tumor Cells
100%
Cell Cycle Progression
100%
Indomethacin
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
83%
Cyclooxygenase-1 (COX-1)
66%
Anticarcinogenic Effects
33%
Antiproliferative Effect
33%
Apoptosis
16%
Inhibitory Effect
16%
Cell Growth
16%
Major Determinants
16%
Cell Viability
16%
M Phase
16%
Growth Parameters
16%
Tumor Growth
16%
Cyclooxygenase-2 Inhibitors
16%
Sulindac
16%
Dimethyl
16%
Lung Metastasis
16%
Blood Platelets
16%
Lewis Lung Carcinoma Cells
16%
Cell Replication
16%
G1 Phase
16%
Primary Tumor Growth
16%
Growth Attenuation
16%
3H-thymidine
16%
Growth Initiation
16%
Cycle Parameters
16%
Cyclooxygenase Inhibitors
16%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide Assay
16%
Thiazol
16%
Thymidine Assay
16%
Moving Tumor
16%
Reduced Cells
16%
Antiproliferative
16%
Cultured Tumor Cells
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Indometacin
100%
Non-Steroidal Anti-Inflammatory Drug
83%
Prostaglandin Synthase
83%
Tumor Growth
33%
Low Drug Dose
33%
Cell Viability
16%
COX-2 Inhibitor
16%
Lung Metastasis
16%
Lewis Carcinoma
16%
Primary Tumor
16%
Sulindac
16%
Thymidine
16%
Tetrazolium
16%
Biphenyl
16%
Veterinary Science and Veterinary Medicine
Neoplasm
100%
Indometacin
100%
In Vitro
100%
Cyclooxygenase
83%
Non-Steroidal Anti-Inflammatory Drug
83%
Mouse
16%
COX-2 Inhibitor
16%
Platelet
16%
Lewis Lung Carcinoma
16%
Sulindac
16%
Lung
16%